Digital Dyadic Empowerment Program on Lifestyle Modification for Chronic Kidney Disease Management
DDEP
1 other identifier
interventional
208
1 country
1
Brief Summary
The goal of this clinical trial is to find out if the Digital Dyadic Empowerment Program (DDEP) can help people with chronic kidney disease (CKD) and their care partners make healthy lifestyle changes. The main questions this study will answer are:
- Does DDEP help protect kidney function?
- Does DDEP support healthier daily habits? Researchers will compare two groups:
- One group will receive the DDEP and get usual medical care.
- The other group will get usual medical care only. Participants will:
- Receive usual care with or without DDEP for six months.
- Visit the clinic at the start and end of the study for health checks and tests.
- Practice healthy habits at home with or without help from DDEP. This study aims to show if adding DDEP to regular care can make it easier for people with CKD and their care partners to live healthier lives.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 24, 2024
CompletedFirst Posted
Study publicly available on registry
January 1, 2025
CompletedStudy Start
First participant enrolled
January 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2025
CompletedResults Posted
Study results publicly available
February 12, 2026
CompletedFebruary 12, 2026
January 1, 2026
9 months
December 24, 2024
January 8, 2026
January 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change From Baseline in eGFR at 6 Months (Patient-specific)
For each patient, change from Baseline (Followup score - Baseline score) in the estimated Glomerular Filtration Rate (eGFR) by the Isotope Dilution Mass Spectrometry - Modification of Diet in Renal Disease (IDMS-MDRD) Equation at 6 months was obtained through the patient's biochemical test reports. Higher eGFR numbers generally indicate better kidney functions.
Before initial intervention and 6 months after initial intervention
Secondary Outcomes (4)
Change From Baseline in CKD Stage at 6 Months (Patient-specific)
Before initial intervention and 6 months after initial intervention
Change From Baseline in TTM Stage at 6 Months (Patient-specific)
Before initial intervention and 6 months after initial intervention
Change From Baseline in Health Promoting Lifestyle at 6 Months (Patient-specific)
Before initial intervention and 6 months after initial intervention
Change From Baseline in Dyadic Adjustment at 6 Months
Before initial intervention and 6 months after initial intervention
Study Arms (2)
Digital Dyadic Empowerment + Usual Care
EXPERIMENTALThe intervention group (Digital Dyadic Empowerment + Usual Care) will receive usual care and utilize LINE, a prominent instant messaging App in Taiwan, to assist in lifestyle modification at home along with support from the significant other.
Usual Care
ACTIVE COMPARATORThe control group will receive usual care only.
Interventions
The Digital Dyadic Empowerment Intervention utilizes LINE, a prominent instant messaging App in Taiwan, integrated with an extended application to deliver comprehensive lifestyle modification support to Chronic Kidney Disease (CKD) dyads. Key features of this intervention include: 1. Access to CKD Health Education Information; 2. Supportive Information for Significant Others; 3. Physiological Values Logging for Self-Monitoring; 4. Reminders for Clinical Appointments and Daily Self-Management Tasks; 5. Kidney Health Diary for Lifestyle Modification Progress Tracking; 6. Frequently Asked Questions (FAQs) and Consultation with Healthcare Providers. This intervention aims to enhance the overall well-being of CKD dyads by promoting education, self-monitoring, adherence to appointments, and efficient communication with healthcare providers.
All patients in this study received regular nephrology care at National Cheng Kung University Hospital. Nephrologists conducted routine examinations and provided diagnoses based on test results. The patient's condition (e.g., changes in kidney function), treatment plan, prognosis, and risks were explained to both the patient and family members. The treatment plan included medication, monitoring blood pressure, dietary and exercise at home, and consultations with the Health Education Center for kidney care or nutrition advice.
Eligibility Criteria
You may qualify if:
- The patient has a diagnosis of Chronic Kidney Disease for at least six months;
- The patient can identify a helpful significant other, and both parties are willing to participate;
- The patient can communicate in Mandarin or Taiwanese.
You may not qualify if:
- The significant other is a healthcare provider;
- The patient or the significant other has a mental illness diagnosis;
- The patient is currently receiving renal replacement therapies;
- Neither the patient nor the significant other uses a smartphone or the LINE messaging app.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Cheng Kung University
Tainan, 70101, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
1. Follow-up (6 months) may be too short to detect eGFR changes. 2. As a single-center trial, enrolling only dyads with smartphone/LINE access and an available significant other, generalizability is limited. 3. Usage (any log-in) may not capture behavior-change quality, and some questionnaires may be insensitive/misaligned. 4. Models did not adjust key prognostic factors (e.g., age, baseline CKD stage). 5. Platform issues and RA support needs warrant cautious interpretation of use-outcome links.
Results Point of Contact
- Title
- Chun-Yi Ho, Research Assistant
- Organization
- Department of Nursing, College of Medicine, National Cheng Kung University
Study Officials
- PRINCIPAL INVESTIGATOR
Miaofen Yen, PhD
National Cheng Kung University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Department of Nursing, College of Medicine
Study Record Dates
First Submitted
December 24, 2024
First Posted
January 1, 2025
Study Start
January 13, 2025
Primary Completion
October 8, 2025
Study Completion
October 15, 2025
Last Updated
February 12, 2026
Results First Posted
February 12, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share